A concise starting point for product review.
Reta (retatrutide, LY-3437943) is a synthetic 39-amino-acid research-grade reference compound that acts as a triple agonist at the GLP-1, GIP and glucagon receptors, with a C20 fatty-diacid side chain providing albumin binding and an extended half-life. It is studied for glucose metabolism, energy expenditure, appetite regulation and weight-management research in laboratory models. Supplied as lyophilized powder at ≥99% HPLC purity, available from 10 mg to 100 mg, with each lot accompanied by an independent third-party report covering identity and net peptide content.
Reta (retatrutide, LY-3437943) is a synthetic 39-amino-acid research-grade reference compound that acts as a triple agonist at the GLP-1, GIP and glucagon receptors, with a C20 fatty-diacid side chain providing albumin binding and an extended half-life. It is studied for glucose metabolism, energy expenditure, appetite regulation and weight-management research in laboratory models. Supplied as lyophilized powder at ≥99% HPLC purity, available from 10 mg to 100 mg, with each lot accompanied by an independent third-party report covering identity and net peptide content.
Key information for quotation.
- Product
- Reta
- Form
- Lyophilized Powder
- CAS
- 2381089-83-2
- Formula
- C221H342N46O68
- Molecular weight
- 4731.4 g/mol
- Listed specifications
- 10mg; 25mg; 50mg; 100mg
Available documentation can be confirmed by order.
Available documents and test items are confirmed according to the selected product, specification and order agreement. Representative document names do not imply that every file is available for every product.